Rather counterintuitively, following some promising news about a pipeline drug, one analyst tracking Eli Lilly (NYSE: LLY) ...

After an 18-month break from social media, British fitness influencer Lilly Sabri made her return in April 2025, opening up to the BBC about the personal crisis she faced during her time away.

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly’s weight-loss drug Zepbound and its ...

Private businesses that give away all profits and also succeed as businesses are scarce; the Newman’s Own food branding ...

Weight loss drugs come at a cost, and it is not the MRP you read on the packaging. There are practical complications that ...

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...

Eli Lilly sued four telehealth firms, but it is adopting a new legal strategy in its fight against compounded GLP-1s.

Eli Lilly escalates its crackdown on unauthorized tirzepatide copies, filing lawsuits against four compounders accused of ...

(Reuters) -Eli Lilly said on Wednesday it had sued four compounders for selling unapproved products containing tirzepatide, ...

Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock ...

Pharmaceutical giant Eli Lilly alleges the companies are selling off-brand versions of its best-selling diabetes and ...

Eli Lilly on Thursday filed lawsuits against four telehealth companies over their sale of compounded versions of the GLP-1 ...